Tirzepatide is a once-weekly injectable medication approved for type 2 diabetes and chronic weight management, offering patients flexibility in administration timing
UV Light Stability Not only is BPC-157 the only peptide that can remain intact in the gut, it is also the only peptide that is not damaged when exposed to Ultraviolet Light, thus further demonstrating its superior stability and efficacy across all conditions and environments
The effects were modest, but the study suggested immune modulation might be part of the benefit
There is one small pilot study in humans (examining knee pain, where 7 of 12 participants reported sustained improvement beyond 6 months) and a 2025 safety study confirming BPC-157 was well tolerated in healthy adults
It also attenuates cardiac remodeling by reducing collagen deposition and cardiomyocyte apoptosis, while decreasing the expression of TGF-1 and phosphorylated-Smad3 [171]
The breadth of the pathways involved explains why BPC-157 is studied across gastrointestinal, musculoskeletal, and neurological recovery models
